REGN CIK: 872589

Regeneron Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
billions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
12.2
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.95
FY22:
4.74
FY23:
4.05
FY24:
3.99
FY25:
3.58
(positive)
billions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
5.20
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
9.33
FY22:
4.86
FY23:
4.20
FY24:
4.78
FY25:
5.23
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.08
FY22:
4.34
FY23:
3.95
FY24:
4.41
FY25:
4.50

All amounts in billions USD Data sources:SEC EDGARTwelve Data